Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Vybion Receives Orphan Drug Designation for INT41 in Huntington's Disease

firstwordpharmaDecember 04, 2018

Tag: INT41 , Vybion , Orphan Drug , Intrabodies , INT41

PharmaSources Customer Service